Navigation Links
Verenium Announces Debt Repurchase
Date:3/11/2011

degree of risk and uncertainty.  These include, but are not limited to, statements related to Verenium's lines of business, operations, capabilities, commercialization activities, corporate partnerships, target markets and future financial performance, results and objectives, all of which are prospective.  Such statements are only predictions, and actual events or results may differ materially from those projected in such forward-looking statements.  Factors that could cause or contribute to the differences include, but are not limited to, risks associated with Verenium's strategic focus, risks associated with Verenium's technologies, risks associated with Verenium's ability to obtain additional capital to support its planned operations and financial obligations, risks associated with Verenium's dependence on patents and proprietary rights, risks associated with Verenium's protection and enforcement of its patents and proprietary rights, the commercial prospects of the industries in which Verenium operates and sells products, Verenium's dependence on manufacturing and/or license agreements, and its ability to achieve milestones under existing and future collaboration agreements, the ability of Verenium and its partners to commercialize its technologies and products (including by obtaining any required regulatory approvals) using Verenium's technologies and timing for launching any commercial products and projects, the ability of Verenium and its collaborators to market and sell any products that it or they commercialize, the development or availability of competitive products or technologies, the future ability of Verenium to enter into and/or maintain collaboration and joint venture agreements and licenses, and risks and other uncertainties more fully described in Verenium's filings with the Securities and Exchange Commission, including, but not limited to, Verenium's annual report on Form 10-K for the year ended December 31, 2010 and any updates con
'/>"/>
SOURCE Verenium Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Worlds Largest Soybean Processing Industrial Complex Converts Half of Capacity to Usage of Vereniums Purifine® PLC Enzymatic Degumming Process Engineered and Installed by Alfa Laval
2. Verenium Corporation to Announce Fourth Quarter and Year-End 2010 Financial Results
3. Verenium to Present at Jefferies 11th Global Clean Technology Conference
4. Verenium Announces Favorable Outcome of Capital Ventures International Lawsuit
5. Verenium to Present at Piper Jaffray Sixth Annual Clean Technology & Renewables Conference
6. Verenium Reports Financial Results for the Third Quarter 2010
7. Verenium to Present at Jefferies 10th Global Clean Technology Conference
8. Verenium and Alfa Laval Announce Extension of Purifine® PLC Enzyme Agreement
9. Verenium Announces Regulatory Approval for Purifine® PLC in China
10. Verenium Launches DELTAZYM® GA L-E5 Enzyme for Fuel Ethanol Production
11. Verenium Appoints Kevin Bracken Vice President of Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... July 11, 2014 Cayenne Medical, ... specializing in the soft tissue reconstruction segment, announced ... System for surgeries involving the shoulder and extremities. ... a novel, inserter-controlled deployment method. The unique delivery ... deployment, anchor pull-out, or anchor displacement (also commonly ...
(Date:7/10/2014)... Toronto, Canada (PRWEB) July 10, 2014 ... often present in very low abundance and are ... quite challenging and time-consuming. , Join presenters Dr. ... Laboratories, and Dr. John Anders, Head of Quality ... mass spectrometer-based approach that can speed detection and ...
(Date:7/10/2014)... Understanding the need for better quality and higher ... that currently exists in this area, ChanTest has recently ... validated ion channel and GPCR cell lines. ChanTest’s ... channels control many critical physiological functions throughout the body. ... to treat a variety of human diseases. , ...
(Date:7/10/2014)... Francisco, CA (PRWEB) July 10, 2014 ... family closer together. The Archer Family purchased a ... contained within DNA, but ended up with a lifetime ... discoveries contained within the family members’ DNA genuinely brought ... had decided to search deeper into genetic history and ...
Breaking Biology Technology:Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 2Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 3Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 2Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 4Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 5
... Roy came into CUNA Mutual Groups IT shop, he wasnt ... Steve Haroldson, retired leaving its IT organization with strong connections ... As the new guy with big shoes to fill, Rick ... ,Rick and CUNA both recognized that when you tie IT ...
... new job-finding site IT chief becomes marketer ... WARF to put on patent-strategy conference ... UW grads get new job-finding site ,The Wisconsin Alumni ... graduates find jobs, called Badger Access . The site uses ...
... Wis. What does it mean to the biotech ... That question should be thoroughly addressed at the Wisconsin ... Labs: Where Science Spawns Novel Therapies. The conference will be ... be a biotechnology showcase about 20 companies, 11 from ...
Cached Biology Technology:CIO of CUNA Mutual Group talks on business-IT fusion 2CIO of CUNA Mutual Group talks on business-IT fusion 3Tech Digest: whats moving in the Midwest (11/3/04) 2Life-sciences conference to feature novel research with clinical potential 2
(Date:7/10/2014)... , June 30, 2014  Aware, Inc. (NASDAQ: ... and services, previously announced on June 26, 2014 that ... dividend of $1.75 per share, or approximately $40 million ... July 10, 2014 and a payment date of July ... that it had set an ex-dividend date for this ...
(Date:7/10/2014)... 2, 2014 It is a great honor ... appointment of the world-renowned Thoracic and Cardiovascular surgeon, Mark ... Dr. Ginsburg, with over 34 years of experience, ... and Good Samaritan Regional Medical Center. Dr. Ginsburg has ... 1980,s and is considered an expert in the implantation ...
(Date:7/10/2014)... , July 3, 2014 Research ... addition of the "Global Gesture Recognition & ... - Forecasts to 2020" report to their ... Global Gesture Recognition & Touch-Less Sensing Market ... around for a while, but the companies were ...
Breaking Biology News(10 mins):NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share 2Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2Global Gesture Recognition & Touch-Less Sensing (2D, 3D, Ultrasonic, IR, Capacitive) Market - Forecasts to 2020 2
... who has watched crime dramas on TV knows that ... from evidence gathered at a crime scene, establish a ... has been wrongly jailed. A lesser known but rapidly ... paternal ancestrya process known as genetic genealogy. The laboratories ...
... symptoms until it has spread to other organs, when it ... great promise for extending survival during later disease stages, but ... of the first discoveries of its kind, UC Davis Cancer ... own repair mechanism and, in so doing, help make chemotherapy ...
... Texas Health Science Center at Houston (UTHSC-Houston) were honored ... at the 2008 American Heart Association,s Scientific Sessions in ... killer. UT faculty members recognized were: Nobel Laureate ... Foundation Institute of Molecular Medicine for the Prevention of ...
Cached Biology News:NIST guides genetic genealogy labs toward improved accuracy 2UC Davis discovery offers hope for treating kidney cancer 2UT faculty members win American Heart Association awards for advancing research 2UT faculty members win American Heart Association awards for advancing research 3
... Rabbits x 2 , ... bleed x1 /each , Immunizations/Boost injections ... (app. 5 ml) x1 /each , ... /each , Final Bleed ~ 100 ml blood ...
Mouse VCAM-1/CD106 MAb (Clone 112702)...
FluoSpheres® biotin-labeled microspheres, 0.2 µm, yellow-green fluorescent (505/515) *1% solids*...
Request Info...
Biology Products: